PHARMACOKINETICS (PK) OF FENOFIBRIC ACID AND ROSUVASTATIN IN SUBJECTS WITH MILD TO MODERATE RENAL IMPAIRMENT.

被引：0
|
作者：
Zhu, T. [1 ]
Williams, L. [1 ]
Awni, W. [1 ]
Smith, W. [2 ]
Locke, C. [1 ]
Pradhan, R. [1 ]
机构：
[1] Abbott Labs, Abbott Pk, IL 60064 USA
[2] New Orleans Ctr Clin Res, Knoxville, TN USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics of sirolimus (rapamycin) in subjects with mild to moderate hepatic impairment
    Zimmerman, JJ
    Lasseter, KC
    Lim, HK
    Harper, D
    Dilzer, SC
    Parker, V
    Matschke, K
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (12): : 1368 - 1372
  • [22] Apixaban Pharmacokinetics and Pharmacodynamics in Subjects with Mild or Moderate Hepatic Impairment
    Frost, Charles E.
    Ly, Van
    Garonzik, Samira M.
    DRUGS IN R&D, 2021, 21 (04) : 375 - 384
  • [23] Apixaban Pharmacokinetics and Pharmacodynamics in Subjects with Mild or Moderate Hepatic Impairment
    Charles E. Frost
    Van Ly
    Samira M. Garonzik
    Drugs in R&D, 2021, 21 : 375 - 384
  • [24] Pharmacokinetics (PK) of palifermin in subjects with different degrees of renal impairment
    Gillespie, B
    Zia-Amirhosseini, P
    Salfi, M
    Wang, J
    Robson, R
    Sullivan, JT
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1071 - 1071
  • [25] Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic Impairment
    Desai, Amit
    Schmitt-Hoffmann, Anne-Hortense
    Mujais, Salim
    Townsend, Robert
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) : 3025 - 3031
  • [26] The pharmacokinetics of dalbavancin in subjects with mild, moderate, or severe hepatic impairment
    J Dowell
    E Seltzer
    M Buckwalter
    T Marbury
    D Simoneau
    E Boudry
    Critical Care, 12 (Suppl 2):
  • [27] Pharmacokinetics of frovatriptan in patients with renal impairment.
    Cohen, AF
    van der Post, J
    Sacks, S
    Marsh, J
    Buchan, P
    CEPHALALGIA, 1999, 19 (04) : 365 - 365
  • [28] The Pharmacokinetics of Voclosporin (VCS) in Renal Impairment.
    Freitag, D.
    Huizinga, R.
    Mayo, P.
    Ling, S.
    Foster, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 335 - 335
  • [29] Pharmacokinetics of pioglitazone in patients with renal impairment.
    Edwards, G
    Eckland, DJA
    DIABETOLOGIA, 1999, 42 : A230 - A230
  • [30] EVOLOCUMAB PHARMACOKINETICS AND ITS EFFECTS ON LDL-C AND PCSK9 LOWERING IN SUBJECTS WITH MILD OR MODERATE HEPATIC IMPAIRMENT.
    Emery, M. G.
    Gibbs, J. P.
    Slatter, J. G.
    Hamilton, L.
    Wasserman, S. M.
    Geller, M.
    Dias, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S69 - S69
12345